A
CGEM icon

AlphaQuest’s Cullinan Oncology CGEM Stock Holding History

AlphaQuest’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,950
Closed -$300K – 385
2025
Q4 		$300K Sell
28,950
-69
-0.2% -$622 0.02% 1212
2025
Q3 		$172K Buy
29,019
+18,555
+177% +$136K 0.01% 1482
2025
Q2 		$78.8K Sell
10,464
-14,626
-58% -$118K 0.01% 1502
2025
Q1 		$190K Buy
+25,090
New +$241K 0.02% 1021
2024
Q4 		– Sell
-20,404
Closed -$342K – 1745
2024
Q3 		$342K Buy
20,404
+18,365
+901% +$326K 0.03% 841
2024
Q2 		$35.6K Sell
2,039
-6,644
-77% -$141K ﹤0.01% 1192
2024
Q1 		$148K Sell
8,683
-8,918
-51% -$138K 0.03% 739
2023
Q4 		$179K Buy
+17,601
New +$156K 0.04% 651

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return